Countries China
iRegene Advances Global Cell Therapy Programme With Key Parkinson’s And MSA Clinical Milestones
The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical...
February 25, 2026 | News
Sciwind Biosciences And Pfizer China Forge Strategic Commercialisation Pact For Ecnoglutide In Mainland China
Hangzhou Sciwind Biosciences Co., Ltd. announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a n...
February 25, 2026 | News
CStone Secures UK MHRA Approval For Sugemalimab In Stage III Non Small Cell Lung Cancer
Following approval by the European Commission (EC), sugemalimab has received a new indication approval from the UK Medicines and Healthcare products...
February 24, 2026 | News
YolTech Reports Positive Interim Data For YOLT 202 In Alpha 1 Antitrypsin Deficiency
Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated with ...
February 23, 2026 | News
Bon Natural Life Establishes Joint Laboratory To Advance Bio Manufactured Natural Ingredients
Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, anno...
February 19, 2026 | News
CARsgen Therapeutics Advances Commercial CAR T Cell Manufacturing With Shanghai Strategic Partnership
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that through its in...
February 17, 2026 | News
Innovent Advances IBI354 Into Pivotal Phase Three Trial For HER2 Positive Advanced Breast Cancer
Innovent Biologics, Inc. ("Innovent",HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medi...
February 16, 2026 | News
Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...
February 16, 2026 | News
Ribo And Ribocure Sign Global Licensing Deal With Madrigal For Six siRNA Programmes In MASH
Suzhou Ribo Life Science Co., Ltd. (HKEX: 06938) ("Ribo") and its subsidiary Ribocure Pharmaceuticals AB ("Ribocure") announced that they have entere...
February 13, 2026 | News
WuXi Vaccines Secures ANVISA GMP Certification For Suzhou Fill And Finish Facility
WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...
February 13, 2026 | News
Insilico Medicine And China Medical System Forge Multi Project AI Drug Discovery Alliance
Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Ho...
February 12, 2026 | News
Ascletis Advances ASC36 Oral Amylin Tablet With Strong Preclinical Weight Loss Data
Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady...
February 12, 2026 | News
AsymBio Builds Integrated End To End Platforms To Accelerate Biopharmaceutical Development
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...
February 12, 2026 | News
DIFF Biotech Secures China Clinical Approval For First Domestic Nasal Spray Influenza Vaccine
Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, ...
February 10, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
